Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

A new mutation in the ST14 gene broadens the understanding of ichthyosis-hypotrichosis syndrome.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

A boy had unusual synchronized hair growth with short active growth phases, not fitting known hair disorders.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Hair loss is mainly caused by a testosterone byproduct, and hair restoration surgery uses hair from the back and sides of the scalp.

The study found that balding scalps have more thin hairs and larger oil glands, which might contribute to skin conditions related to hair loss.

Female pattern hair loss is common, worsens with age, and requires long-term treatment to manage.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Woman has discoid lupus, frontal fibrosing, and androgenetic alopecia.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Different levels of microRNAs in different parts of the scalp can cause male pattern baldness.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

Tight hairstyles under hijabs cause traction alopecia, worsened by prolonged wear.

Women with hair loss have more androgen receptors in certain hair follicles.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Finasteride works for hair loss by maintaining existing hair follicles, not reversing miniaturization.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

The proteins transthyretin and megalin are more present in the growth phase of hair, suggesting they might affect hair health and growth.

Neonate scalp hair is thinner, lacks a medulla, and has smaller follicles compared to adult hair.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The document concludes that while some hair and scalp disorders can be treated, hair loss from destroyed follicles is permanent, and damaged hair can only regrow naturally.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Human scalp hair follicles can produce hormones and have a system similar to a brain-body communication network.